全文获取类型
收费全文 | 1665351篇 |
免费 | 140454篇 |
国内免费 | 6899篇 |
专业分类
耳鼻咽喉 | 22513篇 |
儿科学 | 53713篇 |
妇产科学 | 46993篇 |
基础医学 | 235195篇 |
口腔科学 | 48487篇 |
临床医学 | 148276篇 |
内科学 | 322486篇 |
皮肤病学 | 35418篇 |
神经病学 | 132832篇 |
特种医学 | 68474篇 |
外国民族医学 | 495篇 |
外科学 | 250796篇 |
综合类 | 51560篇 |
现状与发展 | 31篇 |
一般理论 | 551篇 |
预防医学 | 127068篇 |
眼科学 | 38577篇 |
药学 | 129246篇 |
67篇 | |
中国医学 | 6762篇 |
肿瘤学 | 93164篇 |
出版年
2018年 | 17167篇 |
2017年 | 13930篇 |
2016年 | 15315篇 |
2015年 | 18661篇 |
2014年 | 25151篇 |
2013年 | 35804篇 |
2012年 | 49055篇 |
2011年 | 51653篇 |
2010年 | 30909篇 |
2009年 | 29237篇 |
2008年 | 47872篇 |
2007年 | 49830篇 |
2006年 | 50401篇 |
2005年 | 48473篇 |
2004年 | 46921篇 |
2003年 | 44987篇 |
2002年 | 43599篇 |
2001年 | 77157篇 |
2000年 | 79441篇 |
1999年 | 67140篇 |
1998年 | 17434篇 |
1997年 | 16006篇 |
1996年 | 15838篇 |
1995年 | 16467篇 |
1994年 | 15495篇 |
1993年 | 14480篇 |
1992年 | 55705篇 |
1991年 | 54079篇 |
1990年 | 52797篇 |
1989年 | 51038篇 |
1988年 | 47343篇 |
1987年 | 46698篇 |
1986年 | 44383篇 |
1985年 | 42911篇 |
1984年 | 32034篇 |
1983年 | 27551篇 |
1982年 | 16118篇 |
1981年 | 14397篇 |
1979年 | 30428篇 |
1978年 | 21026篇 |
1977年 | 17695篇 |
1976年 | 16652篇 |
1975年 | 17522篇 |
1974年 | 21452篇 |
1973年 | 20651篇 |
1972年 | 18846篇 |
1971年 | 17752篇 |
1970年 | 16274篇 |
1969年 | 15252篇 |
1968年 | 13936篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
4.
Huo Jia Fu Lijun Jin Mengyuan Li Zhaoming Zhang Mingzhi 《Investigational new drugs》2022,40(3):537-545
Investigational New Drugs - Background Chemotherapy resistance is a main reason for treatment failure in extranodal NK/T-cell lymphoma (ENKTL). Interleukin-10 (IL-10) is closely related to... 相似文献
5.
6.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
7.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
8.
9.
目的:基于以价值为基础的定价方法,计算核医学学科新增医疗服务项目镭[223 Ra]骨转移瘤治疗的医疗服务价格。为相关新增医疗服务项目的申报和定价打下循证基础,为合理补偿医务人员劳动价值、提升患者服务项目可及性提供依据。方法:采集2021年3—12月使用“镭核素[223 Ra]骨转移瘤治疗资源投入及费用数据采集表”相关数据,开展专家访谈进行系数赋值和基线对照项目确定,得到镭[223 Ra]骨转移瘤治疗服务各个环节的成本和新增服务的价值。结果:镭[223 Ra]骨转移瘤治疗服务按服务特点分为注射前评估、治疗计划、给药、给药后监测、废弃物处理与监测等环节,各环节3地平均人力耗时分别为104分钟、39分钟、25分钟、72分钟和56分钟,中位物耗成本为48.20元,3地总成本(平均人力成本+中位物耗成本)为763.68元。结合系数赋值结果和基线对比项目,得到新增项目的价值为810.19元。结论:运用基于技术难度和风险程度的价值定价理论,计算镭[223 Ra]骨转移瘤治疗新增医疗服务项目的服务价值,建议以价值作为服务定价依据。该定价公式和研究方法不仅可用于其他核医学学科新增服务项目的定价,还适用于现行医疗服务项目的价格动态调整,为未来学科价格工作提供方法学参考。 相似文献
10.